Insider Activity of Erck Stanley C
Biography of Erck Stanley C
No biography is available at this moment.
No biography is available at this moment.
| 2025-08-13 | MaxCyte, Inc. MXCT | director | 100,000 0.0933% | $1.37 | $137,220 | -10.87% | ||
| 2024-11-01 | Sale | MaxCyte, Inc. MXCT | director | 47,689 0.0448% | $3.72 | $177,403 | -35.54% | |
| 2024-10-02 | Sale | MaxCyte, Inc. MXCT | director | 21,607 0.0196% | $3.71 | $80,162 | -24.73% | |
| 2024-10-01 | Sale | MaxCyte, Inc. MXCT | director | 26,082 0.0241% | $3.78 | $98,590 | -23.78% | |
| 2024-09-04 | Sale | MaxCyte, Inc. MXCT | director | 29,767 0.0288% | $3.97 | $118,175 | -13.85% | |
| 2024-09-03 | Sale | MaxCyte, Inc. MXCT | director | 17,922 0.0171% | $4.10 | $73,480 | -17.24% | |
| 2021-10-04 | Sale | Novavax, Inc. NVAX | President and CEO | 42,829 0.0559% | $176.15 | $7.54M | -59.71% | |
| 2021-10-01 | Sale | Novavax, Inc. NVAX | President and CEO | 49,000 0.0624% | $175.10 | $8.58M | -59.92% | |
| 2021-07-02 | Sale | Novavax, Inc. NVAX | President and CEO | 52,559 0.0699% | $215.89 | $11.35M | -37.69% | |
| 2021-07-01 | Sale | Novavax, Inc. NVAX | President and CEO | 52,620 0.0695% | $212.88 | $11.2M | -36.92% | |
| 2020-11-16 | Sale | Novavax, Inc. NVAX | President and CEO | 104,632 0.1592% | $90.65 | $9.49M | +101.24% | |
| 2020-10-01 | Sale | Novavax, Inc. NVAX | President and CEO | 4 <0.0001% | $108.56 | $434 | +72.98% | |
| 2020-09-30 | Sale | Novavax, Inc. NVAX | President and CEO | 24,462 0.0379% | $110.30 | $2.7M | +67.19% | |
| 2020-09-29 | Sale | Novavax, Inc. NVAX | President and CEO | 8,224 0.0134% | $108.41 | $891,563 | +67.51% | |
| 2020-09-28 | Sale | Novavax, Inc. NVAX | President and CEO | 50,000.02 0.0806% | $110.30 | $5.51M | +62.15% | |
| 2018-05-14 | Novavax, Inc. NVAX | President and CEO | 200,000 0.0518% | $1.65 | $329,240 | -4.73% | ||
| 2017-11-09 | Novavax, Inc. NVAX | President and CEO | 200,000 0.0684% | $1.13 | $226,100 | +43.36% | ||
| 2017-05-11 | Novavax, Inc. NVAX | President and CEO | 50,000 0.016% | $0.84 | $41,980 | +27.96% | ||
| 2016-03-31 | Sale | Novavax, Inc. NVAX | President and CEO | 453,538 0.1683% | $5.18 | $2.35M | -61.24% | |
| 2016-03-30 | Sale | Novavax, Inc. NVAX | President and CEO | 396,018 0.0923% | $3.24 | $1.28M | -60.89% |